The APAC ophthalmic pharmaceutical markets reached USD 2.6 billion in 2008-09, with Japan taking up nearly 70% of the total market. Japan’s ophthalmic market was the first to be developed, when such international suppliers as Pfizer and Alcon entered the market some 30 years ago.

